Percutaneous ventricular assist devices for percutaneous coronary interventions in older patients with heart failure: a target trial emulation

医学 传统PCI 心脏病学 内科学 经皮冠状动脉介入治疗 心力衰竭 围手术期 经皮 危险系数 倾向得分匹配 射血分数 比例危险模型 冠状动脉疾病 狼牙棒 入射(几何) 血运重建 心理干预 心肌梗塞 血管成形术 蒂米 支架 阿昔单抗 心室辅助装置 射血分数保留的心力衰竭 介入心脏病学 弗雷明翰风险评分 肌钙蛋白 低风险
作者
Atsuyuki Watanabe,Yoshihisa Miyamoto,Hiroki A Ueyama,Kosuke Inoue,Roger Laham,Deepak L. Bhatt,Yusuke Tsugawa,Toshiki Kuno
出处
期刊:Heart [BMJ]
卷期号:: heartjnl-2025
标识
DOI:10.1136/heartjnl-2025-326949
摘要

Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during percutaneous coronary interventions (PCI). Since older patients with coronary artery disease and heart failure (HF) are less likely to undergo open heart surgery, given the higher risk of perioperative complications, the analyses on the benefits of pVAD for older patients with HF receiving PCI will be informative. Methods We included Medicare fee-for-service beneficiaries aged 65–99 years with systolic HF receiving PCI from 2017 to 2020. Using a target trial emulation framework, we followed the patients from the date of the index PCI to the maximum of 1 year and examined the incidence of major adverse cardiovascular events (MACE: composite of all-cause mortality, HF readmission, acute myocardial infarction, and stroke), as well as in-hospital outcomes, including postprocedural transfusions, of patients treated with PCI plus pVAD versus PCI plus intra-aortic balloon pump (IABP). We used the propensity score matching approach to control for 58 baseline covariates and applied a Cox regression model to estimate adjusted hazard ratio (aHR). Results We included 5823 patients, from whom 2096 patients were matched. The risk of 1-year MACE was 55.4% (95% CI 52.2–58.5) in the pVAD group versus 54.7% (95% CI 51.4 to 57.8) in the IABP group, with aHR of 0.95 (95% CI 0.83 to 1.10). We did not find evidence that other outcomes differed between patients treated with PCI plus pVAD versus PCI plus IABP, including 1-year mortality (aHR, 0.94; 95% CI,0.79 to 1.12) and postprocedural transfusions (adjusted risk ratio, 1.07; 95% CI 0.75 to 1.52). Our findings were consistent across several sensitivity analyses. Conclusions This observational study using the Medicare databases in the USA did not find evidence that clinical outcomes differed between older patients with systolic HF receiving PCI with pVAD vs PCI plus IABP.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zz完成签到,获得积分10
刚刚
小马甲应助西西想发paper采纳,获得10
刚刚
Z梦完成签到,获得积分10
1秒前
1秒前
南风知我意完成签到,获得积分0
2秒前
Yun发布了新的文献求助10
2秒前
LP829发布了新的文献求助10
3秒前
3秒前
kk完成签到,获得积分10
4秒前
5秒前
Akim应助傅以柳采纳,获得20
5秒前
如意的醉蓝发布了新的文献求助100
5秒前
6秒前
6秒前
充电宝应助kimyb采纳,获得10
6秒前
LL完成签到 ,获得积分10
6秒前
12345完成签到,获得积分10
7秒前
ME发布了新的文献求助10
8秒前
8秒前
嘉心糖应助Iris99采纳,获得30
8秒前
科目三应助牛牛采纳,获得10
9秒前
9秒前
Yun完成签到,获得积分10
10秒前
10秒前
liuzhuohao应助bodhi采纳,获得10
10秒前
10秒前
CodeCraft应助典雅的小懒猪采纳,获得10
11秒前
huahua发布了新的文献求助10
11秒前
蚂蚁咬狗熊关注了科研通微信公众号
12秒前
12秒前
CipherSage应助夜冷瞳采纳,获得10
13秒前
稳重凝荷完成签到,获得积分10
14秒前
酿酒师来了完成签到,获得积分10
15秒前
15秒前
15秒前
16秒前
16秒前
kimyb发布了新的文献求助10
16秒前
16秒前
深情安青应助糊涂的MJ采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
模型平均及其应用 900
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
The Cambridge History of China 英文版16册 600
作者名:Kristopher P. Plain,悉尼大学的,目前只能查到其四篇论文,想找到其博士论文 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7333668
求助须知:如何正确求助?哪些是违规求助? 8948144
关于积分的说明 18984010
捐赠科研通 6987747
什么是DOI,文献DOI怎么找? 3217284
关于科研通互助平台的介绍 2383665
邀请新用户注册赠送积分活动 2197131